scout
Opinion|Videos|May 3, 2024

Clinical Trials Evaluating Lenvatinib Plus Everolimus in Advanced Renal Cell Carcinoma

The panel discusses the lenvatinib plus everolimus regimen for patients with advanced renal cell carcinoma, highlighting clinical trial data on its efficacy and safety profile.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME